Marco Iannetta

2.8k total citations
94 papers, 1.6k citations indexed

About

Marco Iannetta is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Marco Iannetta has authored 94 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 28 papers in Epidemiology and 14 papers in Oncology. Recurrent topics in Marco Iannetta's work include COVID-19 Clinical Research Studies (19 papers), SARS-CoV-2 and COVID-19 Research (15 papers) and Polyomavirus and related diseases (13 papers). Marco Iannetta is often cited by papers focused on COVID-19 Clinical Research Studies (19 papers), SARS-CoV-2 and COVID-19 Research (15 papers) and Polyomavirus and related diseases (13 papers). Marco Iannetta collaborates with scholars based in Italy, France and United States. Marco Iannetta's co-authors include Vincenzo Vullo, Claudio Maria Mastroianni, Giuseppe Ippolito, Emanuele Nicastri, Maria Rosaria Capobianchi, Concetta Castilletti, Giuseppina Liuzzi, Massimo Andreoni, Alessandra Oliva and Alessandra D’Abramo and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Marco Iannetta

87 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Iannetta Italy	23	755	390	354	272	199	94	1.6k
Guillaume Martin‐Blondel France	24	788 1.0×	520 1.3×	723 2.0×	137 0.5×	278 1.4×	113	2.0k
Stefan Schmiedel Germany	23	551 0.7×	294 0.8×	242 0.7×	333 1.2×	302 1.5×	101	1.8k
Carolina Ramı́rez-Santana Colombia	25	1.2k 1.5×	399 1.0×	351 1.0×	690 2.5×	421 2.1×	67	2.8k
Peter Bager Denmark	25	498 0.7×	301 0.8×	204 0.6×	112 0.4×	250 1.3×	60	2.1k
Siegbert Rieg Germany	24	1.0k 1.4×	724 1.9×	348 1.0×	265 1.0×	203 1.0×	118	2.5k
Penny Lewthwaite United Kingdom	16	1.5k 2.0×	462 1.2×	435 1.2×	451 1.7×	203 1.0×	33	2.7k
Svend Ellermann‐Eriksen Denmark	27	565 0.7×	700 1.8×	218 0.6×	182 0.7×	516 2.6×	99	2.0k
Tobias Tenenbaum Germany	31	745 1.0×	900 2.3×	570 1.6×	197 0.7×	498 2.5×	110	3.0k
Jiménez-Mejías Me Spain	24	441 0.6×	566 1.5×	340 1.0×	163 0.6×	77 0.4×	73	2.2k
José Ramón Blanco Spain	31	1.6k 2.1×	657 1.7×	292 0.8×	88 0.3×	174 0.9×	159	3.0k

Countries citing papers authored by Marco Iannetta

Since Specialization

Citations

This map shows the geographic impact of Marco Iannetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Iannetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Iannetta more than expected).

Fields of papers citing papers by Marco Iannetta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Iannetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Iannetta. The network helps show where Marco Iannetta may publish in the future.

Co-authorship network of co-authors of Marco Iannetta

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Iannetta. A scholar is included among the top collaborators of Marco Iannetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Iannetta. Marco Iannetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cesta, Novella, Cesira Giordano, Simona Barnini, et al.. (2025). Characterisation of four novel bacteriophages targeting carbapenem-resistant Klebsiella pneumoniae and their lytic activity alone and in combination. Current Research in Microbial Sciences. 9. 100509–100509.

Cesta, Novella, Adelaide Fusco, Cartesio D’Agostini, et al.. (2025). Bacteriophage-enhanced doxycycline activity against Escherichia coli in chronic bacterial prostatitis. International Journal of Antimicrobial Agents. 66(4). 107571–107571.

Zaçe, Drieda, et al.. (2024). Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis. Drug Safety. 47(4). 333–354. 8 indexed citations

Campogiani, Laura, Luigi Coppola, Mirko Compagno, et al.. (2023). Real-life Data on Cefiderocol Efficacy and Safety to Treat Multidrug-Resistant Acinetobacter baumannii Infections. Open Forum Infectious Diseases. 10(12). ofad627–ofad627. 3 indexed citations

Campogiani, Laura, A Lodi, Carla Fontana, et al.. (2023). Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study. Antibiotics. 12(5). 820–820. 8 indexed citations

Lorenzo, Andrea Di, Laura Campogiani, Marco Iannetta, et al.. (2023). The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy. Antibiotics. 12(9). 1348–1348. 3 indexed citations

Etna, Marilena P., Martina Severa, Stefano Fiore, et al.. (2023). Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model. International Immunopharmacology. 117. 109996–109996. 5 indexed citations

Zingaropoli, Maria Antonella, Patrizia Pasculli, Valentina Perri, et al.. (2023). Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated pwMS and Infectious Risk. Biology. 12(4). 587–587. 3 indexed citations

Rose, Domenico Umberto De, Francesca Ceccherini‐Silberstein, Andrea Dotta, et al.. (2023). T Lymphocyte Subset Counts and Interferon-Gamma Production in Adults and Children with COVID-19: A Narrative Review. Journal of Personalized Medicine. 13(5). 755–755. 3 indexed citations

10.

Rossi, Benedetta, Domenico Benvenuto, Laura Campogiani, et al.. (2023). Human Arboviral Infections in Italy: Past, Current, and Future Challenges. Viruses. 15(2). 368–368. 11 indexed citations

11.

Prezioso, Carla, Marco Ciotti, Francesca Piacentini, et al.. (2022). Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment. Journal of Clinical Medicine. 11(2). 347–347. 3 indexed citations

12.

Iannetta, Marco, Andrea Di Lorenzo, Laura Campogiani, et al.. (2022). Hepatitis B–Related Hepatic Flare During Immune Reconstitution Syndrome After Antiretroviral Treatment Initiation in an HBV Surface Antigen–Positive Patient With HIV: Viroimmunological and Histological Characterization. Open Forum Infectious Diseases. 9(9). ofac451–ofac451. 5 indexed citations

13.

Compagno, Mirko, Assunta Navarra, Laura Campogiani, et al.. (2022). Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome. International Journal of Environmental Research and Public Health. 19(17). 10693–10693. 1 indexed citations

14.

Severa, Martina, Roberta A. Diotti, Marilena P. Etna, et al.. (2021). Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection. PLoS Pathogens. 17(9). e1009878–e1009878. 59 indexed citations

15.

Vita, Serena, Paola Zuccalà, Stefano Savinelli, et al.. (2020). Impact of IFN‐Free and IFN‐Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan‐DC, and Activated T Lymphocyte Dynamics during HCV Infection. Journal of Immunology Research. 2020(1). 2781350–2781350. 2 indexed citations

16.

Iannetta, Marco, Maria Antonella Zingaropoli, Tiziana Latronico, et al.. (2019). Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients. Scientific Reports. 9(1). 14 indexed citations

17.

Ciardi, Maria Rosa, Marco Iannetta, Maria Antonella Zingaropoli, et al.. (2018). Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis. Open Forum Infectious Diseases. 6(1). ofy356–ofy356. 54 indexed citations

18.

Colavita, Francesca, Veronica Bordoni, Claudia Caglioti, et al.. (2018). ZIKV Infection Induces an Inflammatory Response but Fails to Activate Types I, II, and III IFN Response in Human PBMC. Mediators of Inflammation. 2018. 1–6. 18 indexed citations

19.

Iannetta, Marco, Stefano Savinelli, Raffaella Marocco, et al.. (2018). Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters. Immunobiology. 224(2). 231–241. 4 indexed citations

20.

Zingaropoli, Maria Antonella, Marco Iannetta, Simona Pontecorvo, et al.. (2018). JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus. BioMed Research International. 2018. 1–10. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact